Improvements in Ocular Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 July 2024 | Viewed by 177
Special Issue Editor
Special Issue Information
Dear Colleagues,
Vision and sight help people connect with surroundings. There are several diseases that can affect the human eye. Blinding diseases such as macular degeneration, glaucoma, trachoma and corneal infections are common worldwide. In the last 10 years, the field of developing ocular drug delivery systems that can target the front and the back of the eye has progressed. Several ocular delivery systems for therapeutic agents in form of topical gels, eye drops, contact lens, intravitreal implants and injectables has been developed. Improvement of penetration of therapeutic agents through cornea and sclera offers delivery of wide range of drugs via topical application in form of gels and eye drops. Intravitreal implants and injectables offer sustained release of therapeutic agents to target the back of the eye.
The aim of this special issue aims to provide experts insights on the recent improvement in ocular delivery systems. Research areas may include, but, not limited to: novel drug impregnated contact lens, topical ocular delivery systems, sustained release intravitreal injectable systems, implants, nanoparticles for delivery of ocular therapeutics and novel ocular tissues penetration enhancers.
I look forward to receiving your contributions.
Dr. Abeer H. A. Mohamed Ahmed
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ocular drug delivery systems
- topical ocular delivery systems
- contact lenses
- implants
- novel topical delivery systems to target the back of the eye
- nanocarriers as ocular delivery systems
